1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,360 | 1,500 | 11:29 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.09. | ALIKO Scientific Announces Settlement of a Dispute Involving Its US Subsidiary, Which Will Receive USD 2 Million | 263 | Business Wire | Regulatory News:
ALIKO Scientific (Ikonisys SA Euronext Growth Paris: ALIKO), an international life sciences Group dedicated to integrated oncology diagnostics, announces that its wholly-owned... ► Artikel lesen | |
| 15.09. | Aliko Scientific Launches Probantes in Brazil and Establishes a New Molecular Diagnostic Development and Commercial Platform for South America | 386 | Business Wire | Currently being established in Brazil, Probantes is wholly owned by Aliko Scientific and based in Anápolis, Goiás, a major pharmaceutical and life sciences hub.
Probantes will serve... ► Artikel lesen | |
| 07.09. | Aliko Scientific Successfully Launches U.S. Business Development Collaboration With Partner International at ADLM 2026, the World's Largest Molecular Diagnostics Exhibition | 372 | Business Wire | Strong first joint initiative at ADLM (Association for Diagnostics Laboratory Medicine) 2026, providing direct access to major international diagnostics players Significant interest generated... ► Artikel lesen | |
| 24.08. | Aliko Scientific Provides a Financial Update Following the Publication of its FY 2025 Results and Reaffirms Its Business Momentum | 681 | Business Wire | Regulatory News:
ALIKO Scientific (Ikonisys SA Euronext Growth Paris: ALIKO), an international life sciences Group dedicated to integrated oncology diagnostics, today provides additional financial... ► Artikel lesen | |
| 05.08. | Aliko Scientific Signs New Distribution Agreements in Romania and Saudi Arabia, Strengthening Its International Commercial Network | 838 | Business Wire | €1.92 million in Romania and €2.05 million in Saudi Arabia in five-year minimum contractual purchase commitments Agreements covering Aliko Scientific's liquid-based cytology, FISH, microscopy... ► Artikel lesen | |
| 05.08. | XFRA 9W8: WIEDERAUFNAHME/RESUMPTION | 183 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| IKONISYS Aktie jetzt für 0€ handeln | |||||
| 30.07. | Aliko Scientific Reports its Full-Year Financial Results for 2025 and Provides an Update on Its Latest Developments | 853 | Business Wire | Total revenue up 52.6% to €1.64 million (vs. €1.08 million in 2024), driven by Hospitex' full-year contribution and the progressive rollout of Aliko Scientific's offering
EBITDA improved... ► Artikel lesen | |
| 23.07. | Aliko Scientific Tochter unterzeichnet Vereinbarung für Krebs-Screening in Usbekistan | - | Investing.com Deutsch | ||
| 23.07. | Aliko Scientific unit signs Uzbekistan cancer screening deal | 2 | Investing.com | ||
| 23.07. | Aliko Scientific: Hospitex International Signs First Agreement With the Uzbek Oncology Institute for the Feasibility Study of a National Urine24 Screening Project | 385 | Business Wire | Confirmation of the growing international interest in Urine24 and significant recognition of Aliko Scientific's expertise in large-scale oncological diagnostic solutions Immediate launch... ► Artikel lesen | |
| 15.06. | XFRA 9W8: AUSSETZUNG/SUSPENSION | 179 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILIKONISYS EO 0,5... ► Artikel lesen | |
| 25.05. | Aliko Scientific gründet Joint Venture in Brasilien zur Herstellung von FISH-Sonden | 1 | Investing.com Deutsch | ||
| 25.05. | Aliko Scientific signs Brazil JV to manufacture FISH probes | 1 | Investing.com | ||
| 25.05. | Aliko Scientific SA: Aliko Scientific Signs Memorandum of Understanding with BioBrasil for Brazilian FISH Probe Manufacturing Joint Venture | 557 | Business Wire | Aliko Scientific signs Brazilian JV with BioBrasil to manufacture proprietary FISH probes for global diagnostic markets New "instrument probes" model aims to create recurring revenues and... ► Artikel lesen | |
| 19.05. | Aliko Scientific SA: Aliko Scientific Announces Award of Major Five-Year Public Tender at Federico II University Hospital | 430 | Business Wire | Execution of the long-term strategy focused on recurring revenue and developing opportunities for sustainable growth Contract with a potential total value of approximately €620,000, over... ► Artikel lesen | |
| 11.05. | Aliko Scientific SA: Aliko Scientific Signs Strategic Memorandum of Understanding with Cellay Inc. and Secures First Commercial Customer in Arizona | 512 | Business Wire | Regulatory News:
Aliko Scientific SA ("Aliko Scientific" or the "Company") (Euronext Growth Paris: ALIKO), an industrial and financial holding company focused on advanced oncology diagnostics... ► Artikel lesen | |
| 10.03. | Aliko Scientific: Hospitex International Signs Strategic Distribution Agreement With Naturneed for Urine24, Strengthening Its Commercial Footprint in the Italian Urology Diagnostics Market | 570 | Business Wire | Regulatory News:
Hospitex International, part of Aliko Scientific Group (Ticker: ALIKO), announces the signing of a strategic distribution agreement with Naturneed for the commercialization... ► Artikel lesen | |
| 24.02. | Aliko Scientific: Outstanding Success at WHX Labs Dubai With 172 Commercial Leads and Strong Global Interest in the New Integrated Oncology Diagnostics Platform | 528 | Business Wire | Regulatory News:
Aliko Scientific SA (Ticker: ALIKO) previously Ikonisys SA, announces a highly successful first market appearance at WHX Labs Dubai, the world's largest medical trade exhibition... ► Artikel lesen | |
| 18.02. | Aliko Scientific: Francesco Trisolini Appointed as New Group CEO to Pursue the Implementation of the Approved Industrial Plan | 581 | Business Wire | Regulatory News:
Aliko Scientific SA (Ikonisys SA Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution... ► Artikel lesen | |
| 19.12.25 | Ikonisys SA: Ikonisys finalized a Capital Increase and Debt Conversion of EUR 2.72 million with strategic investment from Avantgarde Srl and Alberto Previtali | 572 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MOBILE-HEALTH NETWORK SOLUTIONS | 3,040 | 0,00 % | Mobile-health Network Solutions: Mobile-health Network Solutions Advances AI-Powered Lab Data Analysis to Transform Clinical Decision-Making | Singapore, Singapore--(Newsfile Corp. - August 10, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health ecosystem headquartered in... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,075 | 0,00 % | Morning Market Movers: Veea, NFT Limited, WISeSat.Space, Alignment Healthcare See Big Swings | NEW YORK CITY (dpa-AFX) - At 8:15 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 19,570 | 0,00 % | PROCEPT BioRobotics to Report Third Quarter 2026 Financial Results on November 4th, 2026 | ||
| BRIGHTSPRING HEALTH SERVICES | 63,03 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| HEARTFLOW | 50,54 | 0,00 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| FRESENIUS | 43,505 | +1,17 % | VW und Autobauer im Fokus: DAX vor dem nächsten Schub? Diese Woche wird für Anleger entscheidend | © Foto: Boris Roessler/dpaDer DAX dürfte freundlich in die neue Woche starten. Auch die europäischen Futures liegen im Plus. Doch Öl, Inflation und die beginnende US-Berichtssaison könnten schnell für... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,460 | 0,00 % | Privia Health Group, Inc.: Privia Health to Report Third Quarter 2026 Results on Thursday, November 5 | ||
| SIEMENS HEALTHINEERS | 40,060 | +1,08 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,140 | +0,63 % | EQS-Adhoc: Fresenius Medical Care AG: Wechsel im Vorstandsvorsitz - Shervin J. Korangy folgt auf Helen Giza | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Personalentscheidungen / Vorstand
Fresenius Medical Care AG: Wechsel im Vorstandsvorsitz - Shervin J. Korangy folgt auf Helen... ► Artikel lesen | |
| BILLIONTOONE | 93,02 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| GENEDX | 63,79 | -0,05 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| LIFESTANCE HEALTH GROUP | 12,470 | -0,08 % | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call | ||
| PROGYNY | 28,050 | 0,00 % | Progyny expects 1.2 million new covered lives in 2027 | ||
| CONCENTRA GROUP | 37,530 | 0,00 % | Why Concentra's Quiet Healthcare Business Keeps Winning | ||
| AVEANNA HEALTHCARE | 12,190 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen |
Das Unternehmen IKONISYS SA kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 1,350 Euro und damit +1,50 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IKONISYS SA finden Sie auf Wallstreet Online.